Dyne Therapeutics, Inc. - DYN
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 03, 2026 | Chief Financial Officer | S | D | 5,727.0 | 18.64 | 106,751.28 | 125,373.0 | View | |
| Apr 01, 2026 | — | P | A | 2,000.0 | 17.08 | 34,160.0 | 15,500.0 | View | |
| Mar 13, 2026 | — | P | A | 2,000.0 | 19.35 | 38,700.0 | 13,500.0 | View | |
| Mar 13, 2026 | — | S | D | 129,672.0 | 19.5151 | 2,530,562.05 | 4,644,386.0 | View | |
| Mar 11, 2026 | — | S | D | 281,858.0 | 19.8001 | 5,580,816.59 | 4,774,058.0 | View | |
| Mar 11, 2026 | — | S | D | 219,758.0 | 19.325 | 4,246,823.35 | 5,055,916.0 | View | |
| Mar 11, 2026 | — | S | D | 9,482.0 | 18.2121 | 172,687.13 | 5,275,674.0 | View | |
| Mar 11, 2026 | — | S | D | 177,690.0 | 17.7218 | 3,148,986.64 | 5,285,156.0 | View | |
| Mar 10, 2026 | — | P | A | 3,000.0 | 15.06 | 45,180.0 | 11,500.0 | View | |
| Mar 06, 2026 | Chief Medical Officer | S | D | 904.0 | 14.9 | 13,469.6 | 171,606.0 | View | |
| Mar 06, 2026 | Chief Commercial Officer | S | D | 148.0 | 14.9 | 2,205.2 | 154,581.0 | View | |
| Mar 06, 2026 | CEO & President | S | D | 2,732.0 | 14.9 | 40,706.8 | 374,145.0 | View | |
| Feb 17, 2026 | Chief Commercial Officer | A | A | 90,000.0 | 0.0 | 0.0 | 90,000.0 | View | |
| Feb 17, 2026 | Chief Commercial Officer | A | A | 60,000.0 | 0.0 | 0.0 | 154,729.0 | View | |
| Feb 17, 2026 | Chief Medical Officer | A | A | 130,000.0 | 0.0 | 0.0 | 130,000.0 | View | |
| Feb 17, 2026 | Chief Medical Officer | A | A | 85,000.0 | 0.0 | 0.0 | 172,510.0 | View | |
| Feb 17, 2026 | CEO & President | A | A | 285,000.0 | 0.0 | 0.0 | 285,000.0 | View | |
| Feb 17, 2026 | CEO & President | A | A | 180,000.0 | 0.0 | 0.0 | 376,877.0 | View | |
| Feb 17, 2026 | Chief Financial Officer | A | A | 105,000.0 | 0.0 | 0.0 | 105,000.0 | View | |
| Feb 17, 2026 | Chief Financial Officer | A | A | 65,000.0 | 0.0 | 0.0 | 131,100.0 | View | |
| Dec 23, 2025 | — | A | A | 59,665.0 | 0.0 | 0.0 | 59,665.0 | View | |
| Dec 05, 2025 | Chief Medical Officer | S | D | 880.0 | 20.72 | 18,233.6 | 87,510.0 | View | |
| Dec 05, 2025 | CEO & President | S | D | 2,662.0 | 20.72 | 55,156.64 | 196,877.0 | View | |
| Dec 05, 2025 | Chief Commercial Officer | S | D | 144.0 | 20.72 | 2,983.68 | 94,729.0 | View |